UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Poor agreement between pulmonary capillary wedge pressure and left ventricular end-diastolic pressure in a veteran population

PloS one, 2014-01, Vol.9 (1), p.e87304-e87304

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessing risk in pulmonary arterial hypertension: what we know, what we don't

The European respiratory journal, 2017-08, Vol.50 (2), p.1701353-1701353

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score

PloS one, 2020-11, Vol.15 (11), p.e0241504-e0241504

2020

Link zum Volltext

Verfügbarkeit prüfen

17β-Estradiol Attenuates Hypoxic Pulmonary Hypertension via Estrogen Receptor―mediated Effects

American journal of respiratory and critical care medicine, 2012-05, Vol.185 (9), p.965-980

2012

Link zum Volltext

Verfügbarkeit prüfen

ALCAPA: A Rare Cause of Cardiac Arrest

Chest, 2012-10, Vol.142 (4), p.123A-123B

Selej, Mona, MD

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis

The Journal of heart and lung transplantation, 2018-06, Vol.37 (6), p.696-705

2018

Link zum Volltext

Verfügbarkeit prüfen

Development of macitentan for the treatment of pulmonary arterial hypertension

Annals of the New York Academy of Sciences, 2015-11, Vol.1358 (1), p.68-81

2015

Link zum Volltext

Verfügbarkeit prüfen

Load Adaptability in Patients with Pulmonary Arterial Hypertension

The American journal of cardiology, 2017-09, Vol.120 (5), p.874-882

2017

Link zum Volltext

Verfügbarkeit prüfen

Approaching Higher Dimension Imaging Data Using Cluster-Based Hierarchical Modeling in Patients with Heart Failure Preserved Ejection Fraction

Scientific reports, 2019-07, Vol.9 (1), p.10431-10, Article 10431

2019

Link zum Volltext

Verfügbarkeit prüfen

A claims‐based, machine‐learning algorithm to identify patients with pulmonary arterial hypertension

Pulmonary circulation, 2023-04, Vol.13 (2), p.e12237-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Red Card for White Blood Cells: Leukocytapheresis in Sepsis

The Journal of surgical research, 2011-07, Vol.169 (1), p.21-24

2011

Link zum Volltext

Verfügbarkeit prüfen

Sarcoidosis: A Great Imitator

Chest, 2011-10, Vol.140 (4), p.123A-123B

2011

Link zum Volltext

Verfügbarkeit prüfen

Noncardiogenic Pulmonary Edema in Amlodipine Overdose

Chest, 2011-10, Vol.140 (4), p.130A-130B

2011

Link zum Volltext

Verfügbarkeit prüfen

Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program

Pulmonary circulation, 2022-07, Vol.12 (3), p.e12134-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

Chest, 2021-01, Vol.159 (1), p.337-346

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.321-330

2020

Link zum Volltext

Verfügbarkeit prüfen

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies

Chest, 2019-08, Vol.156 (2), p.323-337

2019

Link zum Volltext

Verfügbarkeit prüfen

Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension

Chest, 2023-05, Vol.163 (5), p.1232-1244

2023

Link zum Volltext

Verfügbarkeit prüfen

Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes

The Journal of heart and lung transplantation, 2023-03, Vol.42 (3), p.377-389

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)

Circulation (New York, N.Y.), 2015-12, Vol.132 (25), p.2403-2411

2015

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner

American journal of respiratory cell and molecular biology, 2018-07, Vol.59 (1), p.114-126

2018

Link zum Volltext

Verfügbarkeit prüfen

DEVELOPMENT OF A SIMPLIFIED RISK CALCULATOR FOR STRATIFYING PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION BASED ON ECHOCARDIOGRAPHIC PARAMETERS IN THE REVEAL DATABASE

Chest, 2021-10, Vol.160 (4), p.A2273-A2274

2021

Link zum Volltext

Verfügbarkeit prüfen

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry

Chest, 2018-07, Vol.154 (1), p.126-135

2018

Link zum Volltext

Verfügbarkeit prüfen

OPUS Registry: Treatment Patterns and Safety of Macitentan in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (PAH-SSc)

Chest, 2017-10, Vol.152 (4), p.A999-A1000

2017

Link zum Volltext

Verfügbarkeit prüfen

APPLICATION OF A BAYESIAN NETWORK MODEL TO PREDICT OUTCOMES IN PULMONARY ARTERIAL HYPERTENSION

Chest, 2018-10, Vol.154 (4), p.1061A-1061A

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Poor agreement between pulmonary capillary wedge pressure and left ventricular end-diastolic pressure in a veteran population

Assessing risk in pulmonary arterial hypertension: what we know, what we don't

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score

17β-Estradiol Attenuates Hypoxic Pulmonary Hypertension via Estrogen Receptor―mediated Effects

ALCAPA: A Rare Cause of Cardiac Arrest

Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis

Development of macitentan for the treatment of pulmonary arterial hypertension

Load Adaptability in Patients with Pulmonary Arterial Hypertension

Approaching Higher Dimension Imaging Data Using Cluster-Based Hierarchical Modeling in Patients with Heart Failure Preserved Ejection Fraction

A claims‐based, machine‐learning algorithm to identify patients with pulmonary arterial hypertension

Red Card for White Blood Cells: Leukocytapheresis in Sepsis

Sarcoidosis: A Great Imitator

Noncardiogenic Pulmonary Edema in Amlodipine Overdose

Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies

Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension

Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)

Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner

DEVELOPMENT OF A SIMPLIFIED RISK CALCULATOR FOR STRATIFYING PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION BASED ON ECHOCARDIOGRAPHIC PARAMETERS IN THE REVEAL DATABASE

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry

OPUS Registry: Treatment Patterns and Safety of Macitentan in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (PAH-SSc)

APPLICATION OF A BAYESIAN NETWORK MODEL TO PREDICT OUTCOMES IN PULMONARY ARTERIAL HYPERTENSION

Suchergebnisse filtern